Novavax COVID-19 vaccine enters second round of human trials

Jul 27, 2020
Visit site
At least one of these vaccine candidates is using recombinant proteins attached to an inert carrier. This could be superior to genomic approaches as it presents the antigen(s) in a format most easily accessible to the immune system.

Is anyone aware of other vaccines using recombinant SARS-CoV-2 proteins instead of its genome?